ESCRS - PO179 - Early Objective And Subjective Postoperative Outcomes Following Bilateral Implantation Of A New Enhanced Monovision Intraocular Lens

Early Objective And Subjective Postoperative Outcomes Following Bilateral Implantation Of A New Enhanced Monovision Intraocular Lens

Published 2022 - 40th Congress of the ESCRS

Reference: PO179 | Type: Free paper | DOI: 10.82333/0sd7-d393

Authors: Richard Mcneely 1 , Jonathan Moore* 1

1Cathedral Eye Clinic,Belfast,United Kingdom

Purpose

To outline the postoperative objective visual and refractive outcomes and subjective patient reported outcomes following implantation of a new enhanced monovision intraocular lens (IOL). 

Setting

Cathedral Eye Clinic, Belfast, Northern Ireland, UK

Methods

The study enrolled 20 patients implanted with the Rayone EMV IOL (Rayner) bilaterally. The refractive target was distance vision in the dominant eye and intermediate vision in the nondominant eye. Refraction, binocular uncorrected (UDVA), binocular uncorrected intermediate (UIVA) and near (UNVA) visual acuities, defocus curves and quality of vision questionnaires (QoV) were evaluated 1 month postoperatively. 

Results

The mean binocular UDVA was -0.03 logMAR 1 month postoperatively. The mean binocular UIVA was 0.23 ± 0.06 UNVA was 0.21 ± 0.06 logMAR. High subjective satisfaction was reported with minimal dysphotopsias and high subjective functional vision.

Conclusions

This new enhanced monovision IOL provides a satisfactory range of vision with minimal visual side effects and high patient satisfaction. Outcomes from a longer postoperative follow-up and with greater numbers will be reported at the conference.